Hypertrophic cardiomyopathy treatment strategy: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Hypertrophic cardiomyopathy}} {{CMG}}; {{AOEIC}} {{LG}} ==Treatment strategy based on clinical presentation== Image:HCM treatment strategy.JPG <br clear="left"/> Adapted f...")
 
 
(No difference)

Latest revision as of 16:26, 11 February 2012

Hypertrophic Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypertrophic Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypertrophic cardiomyopathy treatment strategy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertrophic cardiomyopathy treatment strategy

CDC on Hypertrophic cardiomyopathy treatment strategy

Hypertrophic cardiomyopathy treatment strategy in the news

Blogs on Hypertrophic cardiomyopathy treatment strategy

Directions to Hospitals Treating Hypertrophic cardiomyopathy

Risk calculators and risk factors for Hypertrophic cardiomyopathy treatment strategy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Treatment strategy based on clinical presentation


Adapted from ESC Clinical Practice Guidelines[1] and The management of hypertrophic cardiomyopathy[2].

References

  1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE; et al. (2003). "American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines". Eur Heart J. 24 (21): 1965–91. PMID 14585256.
  2. Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997). "The management of hypertrophic cardiomyopathy". N Engl J Med. 336 (11): 775–85. doi:10.1056/NEJM199703133361107. PMID 9052657.

Template:WS Template:WH